Quantcast
Last updated on April 18, 2014 at 7:47 EDT

Global Insulin Market Expected to Reach USD 32,346.7 Million in 2018, with China Alone Accounting for 10.2%: Transparency Market Research

September 19, 2012

ALBANY, New York, September 19, 2012 /PRNewswire/ –

According to a new market report published by Transparency Market Research
(http://www.transparencymarketresearch.com) “Insulin Market – Global and China
Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 – 2018
[http://www.transparencymarketresearch.com/insulin-market.html ]” the global insulin market
was worth USD 12,476.3 million in 2011 and is expected to reach USD 32,346.7 million in
2018, growing at a CAGR of 12% from 2011 to 2018. In the global market, China is expected
to increase its share in the global insulin market to 10.2% by 2018.

Browse the full report at http://www.transparencymarketresearch.com

http://www.transparencymarketresearch.com/insulin-market.html

The global insulin market is driven by rise in diabetic population worldwide. The
world diabetes population was estimated at 366 million in the year 2011, and is expected
to reach 552 million in 2030. It is estimated that diabetes accounts for 4.6 million
deaths, with cases of people dying due to lack of insulin and not even being diagnosed.
This however, presents a huge supply demand deficit for insulin, with high growth
potential in developing markets. The factors contributing to the insulin market growth
also includes increase in global expenditure on healthcare, strong distribution network,
and high scope in developing economies such as China and India.

It is estimated that worldwide, by year 2030, one in ten people will suffer from
diabetes, giving rise to huge demand for insulin. China, being the most populous nation in
the world, accounts for the largest share of the global diabetic population and eventually
turns out as the most lucrative market for insulin manufacturers.

The China insulin market
[http://www.transparencymarketresearch.com/insulin-market.html ] is projected to grow at a
CAGR twice that of the global insulin market. It was estimated at USD 723.8 million in
2011, and is projected to reach USD 3,299.1 million in the year 2018, growing at a CAGR of
24.6%. Currently, China accounts for 6.1% of the global insulin market in terms of volume,
which was estimated at 22.4 tMU in 2011. The global insulin market by volume is projected
to grow at a CAGR of 7.9% from 2012 – 2018.

The global insulin market has continuously witnessed new advanced product types being
introduced in the market by insulin manufacturers. The recent product type is modern
insulin, which is a genetically engineered version of human insulin, and has been
selectively modified to counter the issues associated with human insulin. Currently,
modern insulin accounts for more than 76% of the global insulin market.

Related & Recently Published Reports by Transparency Market Research

Minimally Invasive Surgery Market
[http://www.transparencymarketresearch.com/prostat-cancer-minimal-invasive-surgery-market.html ]

Global Osteoporosis Market
[http://www.transparencymarketresearch.com/osteoporosis-drug-market.html ]

Global Nutraceuticals Product Market
[http://www.transparencymarketresearch.com/global-nutraceuticals-product-market.html ]

Global Nutraceuticals Ingredients Market
[http://www.transparencymarketresearch.com/nutraceutical-ingredients-market.html ]

surgical equipment market size
[http://www.transparencymarketresearch.com/surgical-equipment-market.html ]

Asthma Drugs Industry
[http://www.transparencymarketresearch.com/asthma-and-copd-market.html ]

Global Spectrometry Market
[http://www.transparencymarketresearch.com/spectrometry-market.html ]

Chromatography Market Trends
[http://www.transparencymarketresearch.com/chromatography-market.html ]

Tablet Market
[http://www.transparencymarketresearch.com/tablet-and-smartphones-market.html ]

Global Ophthalmology Devices Industry
[http://www.transparencymarketresearch.com/ophthalmology-devices-market.html ]

To meet the rising demand, global insulin manufacturers are not only augmenting
existing production facilities, but also expanding their global presence to meet the
supply demand gap. Leading insulin manufacturers are now focusing on reinforcing their
market leadership in China. It includes key global and China insulin market players such
as Novo Nordisk, Sanofi-Aventis, and Eli-Lilly. Together they account for more than 90% of
the global insulin market share.

This research is specially designed to estimate and analyze the demand and performance
of the global and China insulin market in the current market scenario. This research
provides in-depth analysis of insulin manufacturers, product sales, trend analysis by
segments, and demand by geography. The report covers all the major product segments of the
global and China insulin market and provides in-depth analysis, historical data and
statistically refined forecast for the segments covered. The study presents a
comprehensive assessment of the stakeholder strategies and winning imperatives for them by
segmenting the global and China insulin market as below:

By Action

        - Short Acting
        - Pre-mixes
        - Long Acting

By Type

        - Modern
        - Human
        - Animal

By Purchase Type

        - Dosage
        - Bulk

Browse all PharmaceuticalMarket Research Reports
[http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html ]

Upcoming Reports in Pharmaceutical Market

Cancer Biomarkers Market
[http://www.transparencymarketresearch.com/cancer-biomarkers-market.html ]

Health And Wellness Market
[http://www.transparencymarketresearch.com/health-and-wellness-market.html ]

Biotechnology Market
[http://www.transparencymarketresearch.com/biotechnology-market.html ]

Non Small Cell Lung Cancer Market
[http://www.transparencymarketresearch.com/non-small-cell-lung-cancer-market.html ]

Healthcare Equipment Market
[http://www.transparencymarketresearch.com/healthcare-equipment-market.html ]

Genitourinary Drugs Market
[http://www.transparencymarketresearch.com/genitourinary-drugs-market.html ]

The Role of IT and Telecom in Healthcare Industry
[http://www.transparencymarketresearch.com/healthcare-it-telecom.html ]

Medical Education Market
[http://www.transparencymarketresearch.com/medical-education-market.html ]

Biomarkers Market [http://www.transparencymarketresearch.com/biomarkers-market.html ]

Colorectal Cancer Market
[http://www.transparencymarketresearch.com/colorectal-cancer-market.html ]

About Us

Transparency Market Research is a global market intelligence company
[http://www.transparencymarketresearch.com ], providing global business information reports
and services. Our exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are privileged with highly
experienced team of Analysts, Researchers, and Consultants, who use proprietary data
sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material for business
reports.

        Contact
        Sheela AK
        90 Sate Street, Suite 700
        Albany, NY 12207
        Tel: +1-518-618-1030
        USA - Canada Toll Free: +1-866-552-3453
        Email: sales@transparencymarketresearch.com

SOURCE Transparency Market Research


Source: PR Newswire